Sonnet BioTherapeutics Holdings, Inc. (SONN)

SONN Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	4.86	0.15	2.27	3.05	27.62	7.35
Cash & Short-Term Investments	4.86	0.15	2.27	3.05	27.62	7.35
Cash Growth	60.90%	-93.43%	-25.50%	-88.95%	275.81%	20515.10%
Other Receivables	0.67	0.76	0.79	0.72	-	-
Receivables	0.67	0.76	0.79	0.72	-	-
Prepaid Expenses	1.2	1.21	1.68	1.64	1.19	0.29
Total Current Assets	6.73	2.12	4.74	5.41	28.81	7.64
Property, Plant & Equipment	0.12	0.14	0.23	0.3	0.18	0.27
Long-Term Deferred Charges	0.12	0.02	0.05	0.11	-	-
Other Long-Term Assets	0.21	0.49	0.41	-	-	0.08
Total Assets	7.18	2.77	5.43	5.83	28.99	7.99
Accounts Payable	1.64	2.18	2.2	4.75	3.78	2.06
Accrued Expenses	1.39	0.94	3.23	3.19	2.31	2.06
Short-Term Debt	-	-	-	0	0	0.02
Current Portion of Leases	0.09	0.08	0.07	0.05	0.09	0.08
Current Unearned Revenue	-	-	0.02	0.17	0.52	0.5
Other Current Liabilities	0	0	0	0	-	-
Total Current Liabilities	3.12	3.21	5.52	8.16	6.7	4.72
Long-Term Debt	-	-	-	-	-	0.12
Long-Term Leases	0.02	0.05	0.13	0.2	0.03	0.13
Total Liabilities	3.15	3.26	5.66	8.37	6.73	4.97
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	124.88	117.2	110.02	88.87	83.95	39.72
Retained Earnings	-120.84	-117.68	-110.24	-91.41	-61.69	-36.71
Shareholders' Equity	4.04	-0.49	-0.23	-2.54	22.26	3.02
Total Liabilities & Equity	7.18	2.77	5.43	5.83	28.99	7.99
Total Debt	0.11	0.13	0.2	0.26	0.13	0.35
Net Cash (Debt)	4.75	0.02	2.07	2.8	27.5	7
Net Cash Growth	67.58%	-99.10%	-25.98%	-89.83%	292.99%	-
Net Cash Per Share	4.56	0.03	15.96	113.31	-	-
Filing Date Shares Outstanding	3.07	3.01	0.38	0.05	0.02	-
Total Common Shares Outstanding	3.01	0.65	0.22	0.03	0.02	-
Working Capital	3.6	-1.09	-0.79	-2.75	22.11	2.91
Book Value Per Share	1.34	-0.75	-1.03	-80.59	910.35	-
Tangible Book Value	4.04	-0.49	-0.23	-2.54	22.26	3.02
Tangible Book Value Per Share	1.34	-0.75	-1.03	-80.59	910.35	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q